CHILDS JOHN W
SEC insider (Form 3/4/5 filer). CIK 0001027035. Director at Veradermics, Inc (MANE) and 1 other issuer. 19 reported Form 4/5 transactions since Sep 2024; latest on Aug 12, 2026. Located in NEW HAVEN, CT.
Companies CHILDS JOHN W has filed insider reports for
- Veradermics, Inc (MANE): Director
- Biohaven Ltd. (BHVN): Director
CHILDS JOHN W
CIK: 0001027035
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (19 total)
- Aug 12, 2026MANE
Veradermics, Inc
SaleIndirect80K shares at avg. $107.23$8.6M - Aug 12, 2026MANE
Veradermics, Inc
SaleIndirect5K shares at avg. $108.24$541K - Aug 12, 2026MANE
Veradermics, Inc
SaleIndirect15K shares at avg. $106.14$1.6M - Apr 28, 2026BHVN
Biohaven Ltd.
AwardDirectStock Options (Right to buy)
68.7K shares- - Feb 5, 2026MANE
Veradermics, Inc
PurchaseIndirect294.1K shares at avg. $17.00$5.0M - Feb 5, 2026MANE
Veradermics, Inc
ConversionIndirect906.9K shares- - Feb 5, 2026MANE
Veradermics, Inc
ConversionIndirect480.3K shares- - Feb 5, 2026MANE
Veradermics, Inc
ConversionIndirect520.8K shares- - Feb 3, 2026MANE
Veradermics, Inc
AwardDirectStock Option (Right to Buy)
51.5K shares- - Nov 13, 2025BHVN
Biohaven Ltd.
PurchaseIndirect3.3M shares at avg. $7.50$25.0M
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 12, 2026 |  MANE Veradermics, Inc | Sale | 80,000 | $107.23 | $8,578,400 | Indirect |
| Aug 12, 2026 | MANE Veradermics, Inc | Sale | 5,000 | $108.24 | $541,200 | Indirect |
| Aug 12, 2026 | MANE Veradermics, Inc | Sale | 15,000 | $106.14 | $1,592,100 | Indirect |
| Apr 28, 2026 |  BHVN Biohaven Ltd. | Award Stock Options (Right to buy) | 68,693 | - | - | Direct |
| Feb 5, 2026 | MANE Veradermics, Inc | Purchase | 294,117 | $17.00 | $4,999,989 | Indirect |
| Feb 5, 2026 | MANE Veradermics, Inc | Conversion | 906,862 | - | $0 | Indirect |
| Feb 5, 2026 | MANE Veradermics, Inc | Conversion | 480,269 | - | $0 | Indirect |
| Feb 5, 2026 | MANE Veradermics, Inc | Conversion | 520,758 | - | $0 | Indirect |
| Feb 3, 2026 | MANE Veradermics, Inc | Award Stock Option (Right to Buy) | 51,525 | - | - | Direct |
| Nov 13, 2025 | BHVN Biohaven Ltd. | Purchase | 3,333,333 | $7.50 | $24,999,998 | Indirect |
1-10 of 19 transactions